Fountain Healthcare Partners logo

Fountain Healthcare Partners

North America, New York, United States, New York

Description

Fountain Healthcare Partners is an Irish-based life science venture capital fund. Fountain is exclusively focused on the life science

Investor Profile

Fountain Healthcare Partners has made 47 investments, with 2 in the past 12 months and 43% as lead.

Stage Focus

  • Series A (38%)
  • Series B (34%)
  • Series C (15%)
  • Private Equity (4%)
  • Post Ipo Equity (4%)
  • Series D (4%)

Country Focus

  • Ireland (55%)
  • United States (17%)
  • Italy (6%)
  • France (6%)
  • Belgium (6%)
  • United Kingdom (6%)
  • Switzerland (2%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Therapeutics
  • Pharmaceutical
  • Biopharma
  • Clinical Trials
  • Emergency Medicine
  • Robotics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fountain Healthcare Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 6
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 4
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 4
Panakes Partners
Europe, Lombardia, Italy, Milano
Co-Investments: 7
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 4
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Enterprise Ireland
Europe, Dublin, Ireland, Dublin
Co-Investments: 5
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 4
Longitude Capital
North America, California, United States, Menlo Park
Co-Investments: 5
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 5

What are some of recent deals done by Fountain Healthcare Partners?

Neuromod Devices

Dublin, Dublin, Ireland

Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.

BiotechnologyClinical TrialsHealth CareMedicalMedical Device
Series BMar 11, 2025
Amount Raised: $10,853,438
XyloCor Therapeutics

King Of Prussia, Pennsylvania, United States

XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.

BiotechnologyHealth CarePharmaceutical
Series BJan 7, 2025
Amount Raised: $67,500,000
Mainstay Medical

Dublin, Dublin, Ireland

Mainstay Medical is a global medical device company that is developing devices to deliver innovative therapies.

BiotechnologyEmergency MedicineHealth CareMedicalMedical Device
Private EquityFeb 26, 2024
Amount Raised: $125,000,000
MMI

Pisa, Toscana, Italy

MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.

Health CareMedicalMedical DeviceRobotics
Series CFeb 21, 2024
Amount Raised: $110,000,000
Corteria Pharmaceuticals

Paris, Ile-de-France, France

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

BiotechnologyPharmaceuticalTherapeutics
Series ASep 7, 2023
Amount Raised: $69,538,574
Dualyx

Ghent, Oost-Vlaanderen, Belgium

Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.

BiotechnologyHealth CareMedical
Series AMay 15, 2023
Amount Raised: $43,494,004
Neuromod Devices

Dublin, Dublin, Ireland

Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.

BiotechnologyClinical TrialsHealth CareMedicalMedical Device
Series BApr 13, 2023
Amount Raised: $16,577,920
MMI

Pisa, Toscana, Italy

MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.

Health CareMedicalMedical DeviceRobotics
Series BJul 20, 2022
Amount Raised: $75,000,000
Ermium Therapeutics

Paris, Ile-de-France, France

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.

BiotechnologyHealth CarePharmaceutical
Series AJun 30, 2022
Amount Raised: $6,287,068
Vivasure Medical

Galway, Galway, Ireland

Medical device company developing a closure device for vascular access procedures.

BiopharmaHealth CareMedical Device
Series DMay 17, 2022
Amount Raised: $23,000,000